Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

marketwatch.com - Fuji Pharma FY Net Y2.83B Vs Net Y3.00B
Fuji Pharma FY Net Y2.83B Vs Net Y3.00B
MarketWatch –

Fuji Pharma Co. Ltd. (4554.TO) Japan Year Ended September 30 GROUP 2026 2025 Revenue Y62.39 bln Y51.68 bln Operating Profit Y6.36 bln Y4.99 bln Pretax Profit Y6.18 bln Y4.46 bln Net Profit Y2.83 bln Y3.00 bln Per share Earnings Y111.18 Y122.94…

theguardian.com - Julia Kollewe - Pharma firms' focus on weight-loss drugs could put insulin supply at risk, experts warn
Pharma firms' focus on weight-loss drugs could put insulin supply at risk, experts warn
The Guardian –

The gold rush into GLP-1 weight-loss drugs risks diverting pharmaceutical firms' attention away from diabetes treatments such as insulin, the head of the Access to Medicine Foundation has warned. GLP-1 blockbuster medications such as Novo Nordisk's…

theguardian.com - Lucy Mangan - Mums v Big Pharma review - the 'bored, hysterical housewives' who exposed a horrifying scandal
Mums v Big Pharma review - the 'bored, hysterical housewives' who exposed a horrifying scandal
The Guardian –

Tales of corporate or governmental wrongdoing are often hugely complicated. Documents destroyed, witnesses untraceable, endless obfuscations and legal intricacies invoked. If the people doing the uncovering are ordinary folk, unarmed with fancy…

seekingalpha.com - SA Transcripts - Medicus Pharma Ltd. (MDCX) Q3 2026 Earnings Call Transcript
Medicus Pharma Ltd. (MDCX) Q3 2026 Earnings Call Transcript
Seeking Alpha –

Medicus Pharma Ltd. (MDCX) Q3 2026 Earnings Call November 9, 2026 11:30 AM EST Anna Baran-Djokovic - Senior Vice President of Investor Relations Raza Bokhari - CEO & Executive Chairman Faisal Mehmud - Chief Medical Officer Kumaraguru Raja -…

fool.com - Motley Fool Transcribing - Atea Pharma (AVIR) Q3 2026 Earnings Call Transcript
Atea Pharma (AVIR) Q3 2026 Earnings Call Transcript
The Motley Fool –

Chief Executive Officer and Founder - Jean-Pierre Sommadossi Chief Medical Officer - Maria Arantxa Horga Chief Development Officer - Janet J. Hammond Chief Commercial Officer - John F. Vavricka Chief Financial Officer - Andrea J. Corcoran Senior…

fool.com - Motley Fool Transcribing - Medicus Pharma (MDCX) Q3 2026 Earnings Call Transcript
Medicus Pharma (MDCX) Q3 2026 Earnings Call Transcript
The Motley Fool –

Senior Vice President, Investor Relations - Anna Baran-Djokovic Executive Chairman and Chief Executive Officer - Dr. Raza Bokhari President and Chief Financial Officer - Carolyn Bonner Chief Medical Officer - Dr. Faisal Mehmud Net Loss -- $35.9…

broadcastnow.co.uk - Ellie Kahn - Mums vs Big Pharma draws 500K
Mums vs Big Pharma draws 500K
Broadcast –

MONDAY: BBC2 drugs scandal doc short of average as 5's Police: Suspect No 1 wins 9pm Up to the minute industry news Agenda-setting interviews with key industry figures Insight into the latest programme performances Ratings data with viewing trends…

bluewin.ch - 1,000 liters of hydrochloric acid spilled - toxic cloud of vapor over Liestal
1,000 liters of hydrochloric acid spilled - toxic cloud of vapor over Liestal
bluewin.ch –

In the Oristal industrial park in Liestal, Canton Basel-Landschaft, approximately 1,000 liters of hydrochloric acid leaked at the Dragon Pharma facility. According to Alertswiss, a cloud of vapor has formed. Authorities are warning of the possible…

bbc.co.uk - Malcolm Boyden  - Evesham mother told epilepsy drug would not harm unborn baby
Evesham mother told epilepsy drug would not harm unborn baby
BBC –

Rosemary Nayler says she was repeatedly told that taking the epilepsy drug sodium valproate while pregnant would not affect her unborn child. But it is thought thousands of children in the UK have been left with disabilities caused by the…

bbc.co.uk - Malcolm Boyden  - Evesham mother told epilepsy drug would not harm unborn baby
Evesham mother told epilepsy drug would not harm unborn baby
BBC –

Malcolm Boyden, BBC Hereford & Worcester and Andrew Dawkins, West Midlands Rosemary Nayler says she was repeatedly told that taking the epilepsy drug sodium valproate while pregnant would not affect her unborn child. But it is thought thousands of…

fastcompany.com - Greg Satell - Before you trust consultants' 'research,' look for these red flags
Before you trust consultants' 'research,' look for these red flags
Fast Company –

When Enron, which Fortune named “America's Most Innovative Company” for six consecutive years, collapsed in 2001, there was no shortage of blame to go around. Many blamed corruption and greed, others hubris, and still others…

bbc.co.uk - Edward Sault - Sodium valproate documentary airs as Bognor Regis mum tells story
Sodium valproate documentary airs as Bognor Regis mum tells story
BBC –

A couple from Bognor Regis whose children were harmed by an epilepsy drug used during pregnancy have said they fear for the future as the wait for financial redress goes on. Janet Stockley-Pollard, who took sodium valproate, branded as Epilim…

bbc.co.uk - Edward Sault - Sodium valproate documentary airs as Bognor Regis mum tells story
Sodium valproate documentary airs as Bognor Regis mum tells story
BBC –

Edward Sault, In Bognor Regis and Cash Murphy, South East A couple from Bognor Regis whose children were harmed by an epilepsy drug used during pregnancy have said they fear for the future as the wait for financial redress goes on. Janet…

fool.com - The Motley Fool Team - Doximity: 3 Key Takeaways for Long-Term Investors
Doximity: 3 Key Takeaways for Long-Term Investors
The Motley Fool –

On its fiscal 2027 second-quarter earnings call, held on Nov. 5, 2026, Doximity (DOCS +1.11%) reported revenue of $175 million as artificial intelligence adoption expanded across its platform. Clinicians rely on Doximity's digital tools for daily…

fool.com - Motley Fool Transcribing - Paysign (PAYS) Q3 2026 Earnings Call Transcript
Paysign (PAYS) Q3 2026 Earnings Call Transcript
The Motley Fool –

President and Chief Executive Officer - Mark Newcomer Chief Financial Officer - Jeffery Baker President of Patient Affordability - Matt Turner Chief Payments Officer - Matt Lanford Revenue -- $30.8 million, growing 42.6% year over year driven by…

Receive a Daily briefing on Pharma Industry News

Get Started